Comparison of viral control between two tenofovir dose reduction regimens (300 mg every 48 hours versus 300 mg every 72 hours) in chronic hepatitis B patients with moderate renal impairment from tenofovir‐induced renal dysfunction

2020 ◽  
Author(s):  
Watcharasak Chotiyaputta ◽  
Karn Poosanasuwansri ◽  
Kraiwiporn Kiattisunthorn ◽  
Siwaporn Chainuvati ◽  
Tawesak Tanwandee
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Renal Impairment ◽  
Renal Dysfunction ◽  
Dose Reduction ◽  
Chronic Hepatitis B ◽  
Moderate Renal Impairment ◽  
Viral Control

scholarly journals Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil

Hepatology ◽  
2009 ◽  
Vol 50 (3) ◽  
pp. 727-734 ◽  
Author(s):  
Nghi B. Ha ◽  
Nghiem B. Ha ◽  
Ruel T. Garcia ◽  
Huy N. Trinh ◽  
Andrew A. Vu ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Renal Dysfunction ◽  
Chronic Hepatitis B ◽  
Adefovir Dipivoxil

Treatment of chronic hepatitis B and renal impairment in patients with and without cirrhosis

2018 ◽  
Vol 68 ◽  
pp. S511-S512
Author(s):  
V. Vu ◽  
S. Trinh ◽  
A. Le ◽  
T. Johnson ◽  
J. Hoang ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Renal Impairment ◽  
Chronic Hepatitis B

scholarly journals Renal impairment and hypophosphatemia in chronic hepatitis B patients treated with adefovir dipivoxil

Kanzo ◽  
2016 ◽  
Vol 57 (9) ◽  
pp. 468-474
Author(s):  
Masayuki Miyazaki ◽  
Kenta Motomura ◽  
Taiji Mutsuki ◽  
Takeshi Senjyu ◽  
Masayoshi Yada ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Renal Impairment ◽  
Chronic Hepatitis B ◽  
Adefovir Dipivoxil
Sign in / Sign up

Export Citation Format

Share Document